DK1729732T3 - Anioniske hydrogelmatricer med pH-afhængig frigivelse som lægemiddelbærere - Google Patents
Anioniske hydrogelmatricer med pH-afhængig frigivelse som lægemiddelbærereInfo
- Publication number
- DK1729732T3 DK1729732T3 DK05718991T DK05718991T DK1729732T3 DK 1729732 T3 DK1729732 T3 DK 1729732T3 DK 05718991 T DK05718991 T DK 05718991T DK 05718991 T DK05718991 T DK 05718991T DK 1729732 T3 DK1729732 T3 DK 1729732T3
- Authority
- DK
- Denmark
- Prior art keywords
- drug carriers
- hydrogel matrices
- dependent release
- anionic hydrogel
- matrices
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000168A ITRM20040168A1 (it) | 2004-04-01 | 2004-04-01 | Composizione a rilascio modificato ph dipendente. |
| PCT/IT2005/000081 WO2005094792A1 (en) | 2004-04-01 | 2005-02-16 | Anionic hydrogel matrices with ph dependent modified release as drug carriers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1729732T3 true DK1729732T3 (da) | 2009-08-10 |
Family
ID=34961555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK05718991T DK1729732T3 (da) | 2004-04-01 | 2005-02-16 | Anioniske hydrogelmatricer med pH-afhængig frigivelse som lægemiddelbærere |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20070166383A1 (da) |
| EP (1) | EP1729732B1 (da) |
| JP (1) | JP2007530666A (da) |
| KR (1) | KR20060133578A (da) |
| CN (1) | CN1913875B (da) |
| AT (1) | ATE428405T1 (da) |
| AU (1) | AU2005228716B2 (da) |
| BR (1) | BRPI0509475A (da) |
| CA (1) | CA2551797A1 (da) |
| CY (1) | CY1109209T1 (da) |
| DE (1) | DE602005013935D1 (da) |
| DK (1) | DK1729732T3 (da) |
| ES (1) | ES2325626T3 (da) |
| HR (1) | HRP20090329T1 (da) |
| IT (1) | ITRM20040168A1 (da) |
| PL (1) | PL1729732T3 (da) |
| PT (1) | PT1729732E (da) |
| RS (1) | RS51178B (da) |
| SI (1) | SI1729732T1 (da) |
| WO (1) | WO2005094792A1 (da) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4746883B2 (ja) * | 2005-01-28 | 2011-08-10 | リンテック株式会社 | ハイドロゲル基剤、パップ剤基剤、パップ剤及び水性ゲルシート |
| EP2379226B1 (en) | 2008-12-31 | 2016-04-20 | 3M Innovative Properties Company | Live bioload detection using microparticles |
| JP2012513768A (ja) | 2008-12-31 | 2012-06-21 | スリーエム イノベイティブ プロパティズ カンパニー | サンプリング装置及び微生物を濃縮するための方法 |
| US9284593B2 (en) | 2009-12-30 | 2016-03-15 | 3M Innovative Properties Company | Live bioload detection using microparticles |
| US8845801B2 (en) | 2009-12-30 | 2014-09-30 | Regents Of The University Of Minnesota | Bone cement and method |
| KR101228106B1 (ko) * | 2010-01-21 | 2013-02-01 | 광주과학기술원 | 피부투과도, 세포유입 및 종양전달성이 증가된 나노운반체 |
| WO2011090349A2 (ko) * | 2010-01-21 | 2011-07-28 | 광주과학기술원 | 피부투과도, 세포유입 및 종양전달성이 증가된 나노운반체 |
| CN103330702B (zh) * | 2013-07-02 | 2016-03-02 | 江苏长泰药业有限公司 | 含有拟交感神经胺盐和诱导凝胶体系的医药组合物 |
| CN108452291A (zh) * | 2018-07-04 | 2018-08-28 | 西南大学 | 用天然丝胶蛋白治疗溃疡性结肠炎的方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4071508A (en) * | 1975-02-11 | 1978-01-31 | Plastomedical Sciences, Inc. | Anionic hydrogels based on hydroxyalkyl acrylates and methacrylates |
| IT1284661B1 (it) * | 1996-06-06 | 1998-05-21 | Sigma Tau Ind Farmaceuti | Uso di alcanoil l-carnitine nel trattamento terapeutico di malattie infiammatorie croniche intestinali. |
| DE19653631A1 (de) * | 1996-12-20 | 1998-06-25 | Basf Coatings Ag | Verfahren zum Herstellen von durch Strahlung vernetzbaren polymeren Acryl- oder Methacrylsäureestern |
| PT986408E (pt) * | 1997-06-03 | 2005-09-30 | Innogenetics Nv | Novos medicamentos baseados em polimeros compostos por gelatina modificada com metacrilamida |
| DE60021059T2 (de) * | 1999-02-03 | 2006-05-18 | Powderject Research Ltd. | Partikuläre pharmazeutische Zusammensetzung für eine transdermale Partikelabgabe aus einem nadellosen Spritzensystem |
| US6547182B2 (en) * | 2001-07-19 | 2003-04-15 | Aerojet-General Corporation | Solid rocket motor bolted thrust takeout structure |
| US7204997B2 (en) * | 2002-01-29 | 2007-04-17 | Supratek Pharma Inc. | Responsive microgel and methods related thereto |
-
2004
- 2004-04-01 IT IT000168A patent/ITRM20040168A1/it unknown
-
2005
- 2005-02-16 AU AU2005228716A patent/AU2005228716B2/en not_active Ceased
- 2005-02-16 PL PL05718991T patent/PL1729732T3/pl unknown
- 2005-02-16 ES ES05718991T patent/ES2325626T3/es active Active
- 2005-02-16 CA CA002551797A patent/CA2551797A1/en not_active Abandoned
- 2005-02-16 BR BRPI0509475-5A patent/BRPI0509475A/pt not_active IP Right Cessation
- 2005-02-16 WO PCT/IT2005/000081 patent/WO2005094792A1/en active Application Filing
- 2005-02-16 AT AT05718991T patent/ATE428405T1/de active
- 2005-02-16 CN CN2005800036356A patent/CN1913875B/zh not_active Expired - Fee Related
- 2005-02-16 DK DK05718991T patent/DK1729732T3/da active
- 2005-02-16 EP EP05718991A patent/EP1729732B1/en active Active
- 2005-02-16 PT PT05718991T patent/PT1729732E/pt unknown
- 2005-02-16 SI SI200530711T patent/SI1729732T1/sl unknown
- 2005-02-16 US US10/596,267 patent/US20070166383A1/en not_active Abandoned
- 2005-02-16 JP JP2007505744A patent/JP2007530666A/ja active Pending
- 2005-02-16 DE DE602005013935T patent/DE602005013935D1/de active Active
- 2005-02-16 RS RSP-2009/0315A patent/RS51178B/sr unknown
- 2005-02-16 KR KR1020067016168A patent/KR20060133578A/ko not_active Application Discontinuation
-
2009
- 2009-06-03 HR HR20090329T patent/HRP20090329T1/xx unknown
- 2009-07-03 CY CY20091100701T patent/CY1109209T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE428405T1 (de) | 2009-05-15 |
| AU2005228716A1 (en) | 2005-10-13 |
| RS51178B (sr) | 2010-10-31 |
| PL1729732T3 (pl) | 2009-09-30 |
| EP1729732A1 (en) | 2006-12-13 |
| SI1729732T1 (sl) | 2009-08-31 |
| DE602005013935D1 (de) | 2009-05-28 |
| JP2007530666A (ja) | 2007-11-01 |
| EP1729732B1 (en) | 2009-04-15 |
| PT1729732E (pt) | 2009-07-02 |
| CA2551797A1 (en) | 2005-10-13 |
| CY1109209T1 (el) | 2014-07-02 |
| AU2005228716B2 (en) | 2010-07-15 |
| KR20060133578A (ko) | 2006-12-26 |
| BRPI0509475A (pt) | 2007-09-11 |
| US20070166383A1 (en) | 2007-07-19 |
| CN1913875A (zh) | 2007-02-14 |
| HRP20090329T1 (en) | 2009-09-30 |
| ES2325626T3 (es) | 2009-09-10 |
| CN1913875B (zh) | 2011-08-31 |
| WO2005094792A1 (en) | 2005-10-13 |
| ITRM20040168A1 (it) | 2004-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1729732T3 (da) | Anioniske hydrogelmatricer med pH-afhængig frigivelse som lægemiddelbærere | |
| DK1792927T3 (da) | Ny blokcopolymer, micelletilberedning og anticancermiddel indeholdende samme som aktiv ingrediens | |
| EP2308870A3 (en) | 2-oxo-1-pyrrolidine deriatives, processes for preparing them and their uses | |
| DOP2006000179A (es) | 7-aza-indazoles sustituidos, composiciones que les contienen, procedimiento de fabricación y utilización | |
| EA201000089A1 (ru) | Применение гомо- и сополимеров для стабилизации составов активных ингредиентов | |
| ES2156603T3 (es) | Medicamentos a base de una mezcla sinergetica de metronidazol y de clindamicina. | |
| TW200800967A (en) | Benzimidazole thiophene compounds | |
| AR052238A1 (es) | Formulacion de tabletas estables | |
| DK1863812T3 (da) | Dipeptidylpeptidase-IV-inhiberende forbindelser, fremgangsmåder til fremstilling af de samme og farmaceutiske sammensætninger indeholdende de samme som aktive midler | |
| BRPI0518869A2 (pt) | agentes citotàxicos compreendendo taxanos | |
| JO3408B1 (ar) | مركبات بترين سلفون اميد ثيازول و أوكسازول | |
| DOP2006000268A (es) | Agentes antibacterianos | |
| NO20081479L (no) | 7-(2-Amino-1-hydroksyetyl)-4-hydroksybenzotiazol-2(3H)-ondenvater som beta2-adrenoceptoragonister | |
| NO20073026L (no) | 2-alkoksy-3,4,5-trihydroksy-alkylamider, fremstilling og sammensetninger derav samt anvendelse derav | |
| NO20071871L (no) | Fosfoindoler som HIV-inhibitorer. | |
| FR2894143B1 (fr) | Composition a liberation prolongee de l'actif, son procede de preparation et son utilisation. | |
| NO20064808L (no) | Orale matrixformuleringer med licarbazepin | |
| WO2006056695A8 (fr) | Bengamides possedant un cycle caprolactame substitue, procede de preparation, compositions les contenant et utilisation | |
| UA100850C2 (ru) | Средство для борьбы с паразитами на животных | |
| WO2007025994A3 (fr) | Utilisation d'au moins un 2-alkyle furane, a titre de principe actif depigmentant ou eclaircissant | |
| BRPI0520821A2 (pt) | formulações farmacêuticas de fenofibrato com biodisponibilidade melhorada | |
| PA8627401A1 (es) | Composiciones diuréticas de liberación prolongada | |
| TW200633717A (en) | Process for and intermediates in the preparation of canfosfamide and its salts, pharmaceutical compositions containing some intermediates, and their use as anticancer agents | |
| TW200610526A (en) | Novel hydrophilic analogs of 4,8-dihydrobenzodithiophene-4,8-diones as anticancer agents | |
| TNSN07438A1 (en) | Prolonged release formulation of active principles having a ph-dependent solubility |